In Pseudomonas aeruginosa PAO the anabolic ornithine carbamoyltransferase (OTCase, EC 2.1.3.3) is the product of the argF gene and the only arginine biosynthetic enzyme whose synthesis is repressible by arginine. We have determined the complete nucleotide sequence of the argF gene including its promoter-control region. The deduced amino acid sequence of the anabolic OTCase consists of 305 residues (Mr 33,924), and this was confirmed by the N-terminal amino acid sequence, the total amino acid composition, and the subunit Mr of the purified enzyme. The native anabolic OTCase (Mr 110,000 to 125,000) was found to be a trimer by cross-linking experiments. P. aeruginosa also has a catabolic OTCase (the arcB gene product), which catalyzes the reverse reaction of the anabolic conversion. At the nucleotide sequence level, the P. aeruginosa argF gene had 52.4% identity with the arcB gene. The Escherichia coli argF and argI genes, which code for anabolic OTCase isoenzymes, had 47.3 and 44.9% identity, respectively, with the P. aeruginosa argF sequence. This suggests that these four genes have evolved from a common ancestral gene. The arcB gene appears to be more closely related to the E. coli argF gene than to the P. aeruginosa argF gene. Two transcripts (mRNA-1, mRNA-2) of the P. aeruginosa argF gene were identified by S1 mapping. The transcription initiation site for mRNA-1 was preceded by sequences having partial homology with the E. coli -35 and -10 consensus promoter sequences. No sequence similar to consensus promoters of enteric bacteria was found upstream of the 5' end of mRNA-2. E. coli carrying a P. aeruginosa argF+ recombinant plasmid produced mRNA-1 with low efficiency but no (or very little) mRNA-2. Arginine repressed argF transcription in P. aeruginosa. In the argF promoter region no sequence homologous to the "arg box" (arginine operator module) of E. coli was found. The mechanism of arginine repression in P. aeruginosa thus appears to be different from that in E. coli.
Pseudomonas aeruginosa PAO has two ornithine carbamoyltransferases (OTCases; EC 2.1.3.3). The anabolic OTCase, which is the product of the argF gene [designated argF(P) in this study], catalyzes the sixth reaction of arginine biosynthesis: ornithine + carbamoylphosphate -b citrulline + phosphate (15) . The catabolic OTCase promotes the reverse reaction. This enzyme is the second enzyme of anaerobic arginine catabolism and the product of the arcB gene (2, 14, 35, 47) . Both the anabolic and the catabolic OTCases function unidirectionally in P. aeruginosa. Thus, in arcB mutants the anabolic enzyme does not assume a catabolic function, and in argF(P) mutants the catabolic enzyme does not carry out the biosynthetic reaction (14, 15) . However, specific mutation in the arcB gene can produce a modified enzyme with anabolic function (14) . In a previous immunological study no cross-reaction was found between the anabolic OTCases of P. aeruginosa or Pseudomonas putida and antibodies raised against the catabolic OTCase of P. putida (12) . It was therefore not clear whether the anabolic and catabolic OTCases of P. aeruginosa are quite different proteins or whether they are in fact structurally similar. To answer this question, we determined the nucleotide sequence of the argF(P) gene and investigated the quarternary structure of the purified anabolic OTCase from the same organism. This allowed us to make comparisons with the known sequences and structures of other OTCases, notably the catabolic arcB enzyme from P. aeruginosa (2) and the two anabolic argF [designated argF(E) herein] and argI isoenzymes from Escherichia coli K-12 (3, 48) . We found that all of these enzymes had substantial sequence similarities.
In P. aeruginosa, the anabolic OTCase is the only arginine biosynthetic enzyme whose synthesis is repressed by exogenous arginine (25, 49) ; the arginine biosynthetic pathway is controlled essentially by feedback inhibition of the first two enzymes (17, 18) . Little is known about the mechanism of argF(P) repression because no regulatory mutants are available. By contrast, regulation of arginine biosynthesis has been studied extensively in E. coli K-12, in which the argR repressor controls the synthesis of all enzymes of the pathway (9) . The cloned P. aeruginosa argF(P) gene is not subjected to argR control in E. coli (7, 29) ; in the reciprocal situation, the argF(E) gene is not repressible in P. aeruginosa (29) . Thus, there is no close relationship between the arginine regulatory systems of P. aeruginosa and E. coli. In this study we show that the synthesis of the anabolic OTCase in P. aeruginosa is regulated at the level of transcription, and we discuss the possibility of two overlapping promoters being involved in argF(P) transcription. Media and growth conditions. Complete medium, minimum medium E (MME), minimum medium P (MMP), and M9 medium were described previously (15, 29, 40) . Cultures were grown aerobically at 37°C. P. aeruginosa strains carrying recombinant plasmids were cultivated with carbenicillin (300 ,ug/ml).
Purification of plasmid DNA and conditions for restriction digests and ligation. Plasmid DNA was purified and manipulated as described previously (27) . Restriction enzymes and T4 DNA ligase were purchased from Toyobo (Osaka, Japan), Takara Shuzo (Kyoto, Japan), Boehringer GmbH (Mannheim, Federal Republic of Germany), and New England Biolabs (Beverly, Mass.). Construction of deletions by the use of exonuclease III. A set of deletion derivatives of pYI1 [pUC18 plus a 3.3-kilobases (kb) KpnI-SalI argF(P) fragment; see Results] were constructed by utilizing exonuclease III (19) . The conditions for the treatments with exonuclease III, S1 nuclease, and T4 DNA ligase were essentially as described by Henikoff (19 (19) . Samples (20 pl) were applied to a 0.8% agarose gel to assess the rate of exonuclease digestion. Under these conditions ca. 100 to 150 base pairs (bp) was removed per min. The remaining DNA was pelleted with ethanol and treated with Klenow DNA polymerase I (Takara Shuzo) in the presence of 0.1 mM each dATP, dGTP, dCTP, and dTTP to fill in the ends. DNA was then circularized by T4 DNA ligase and transformed into E. coli JM1O1.
DNA sequencing. Nucleotide sequences were determined by the dideoxy-chain termination method (2, 44) except that 7-deaza dGTP (Boehringer) was used instead of dGTP to avoid G+C compression (42) . Deletion derivatives of pYIl were used for sequencing by cloning appropriate fragments into M13mpll and M13mpl8. At least 300 bp was sequenced from each deletion endpoint. This strategy gave sufficient sequence overlaps on both strands within the argF(P) gene. Assay of anabolic OTCase. Cell extracts were prepared by sonication and the enzyme activity was measured as described previously (14, 15) . One unit is the amount of the enzyme that catalyzes the formation of 1 ,umol of citrulline per h. Protein concentrations were determined by the method of Lowry et al.
Purification of anabolic OTCase. The protocol used for the purification of the E. coli W argF gene product (31) was adapted to the P. aeruginosa argF(P) enzyme. All procedures were conducted at 4°C unless otherwise stated. Strain PAO317(pME202) was grown in a 15-liter fermentor. Exponentially growing bacteria were harvested by centrifugation, washed in 0.9% NaCl, and stored at -20°C. The cells from three batches were suspended in 100 mM potassium phosphate buffer (pH 7.5) containing 100 mM L-ornithine and 0.5 mM P-mercaptoethanol and then disrupted by sonication (31) . The cell extract was heated at 60°C for 10 min and cooled in an ice bath. The solids were discarded by centrifugation. After precipitation by ammonium sulfate (30 to 60% saturation), the enzyme was redissolved in 50 mM potassium phosphate buffer (pH 7.5) and dialyzed against the same buffer. This fraction was chromatographed on a DEAE Sepharose CL-6B column (5 by 20 cm). After the column was washed with 50 mM potassium phosphate buffer, the enzyme was eluted by a linear potassium phosphate gradient (50 to 300 mM, 1 liter). The most active fractions were pooled and concentrated by membrane filtration with a PM 10 membrane (Diaflow, Amicon Corp., Lexington, Mass.). The proteins were then precipitated by the addition of solid ammonium sulfate to reach 80% saturation and further purified by molecular sieving on Sephadex G-200 as described previously (31) . Residual impurities were removed by hydroxyapatite chromatography (Bio-Gel HTP; Bio-Rad Laboratories). The column (2.5 by 30 cm) was equilibrated with 20 mM potassium phosphate (pH 6.8). Anabolic OTCase was eluted by a 500-ml linear gradient of 20 to 125 mM potassium phosphate buffer (pH 6.8). Fractions containing the enzyme were pooled and stored frozen at -20°C.
Mr determination. The Mr of purified native anabolic OTCase was estimated by gel filtration on a Sephadex G-200 column by using urease (Mr 480,000), catalase (Mr 230,000), hexokinase (Mr 96,000), and alkaline phosphatase (Mr 78,000) as standard markers and blue dextran 2000 as the void volume indicator. Blue dextran was determined at 660 nm. Enzymes were located by enzyme assays.
Polyacrylamide gel electrophoresis and cross-linking of anabolic OTCase. Electrophoresis of anabolic OTCase in the presence of sodium dodecyl sulfate (SDS) was performed as described by Weber et al. (50) with 7.5% polyacrylamide gels. Standard marker proteins were lysozyme (Mr 14,300), soybean trypsin inhibitor (Mr 20,100), carbonic anhydrase (Mr 28,700), ovalbumin (Mr 42,800), bovine serum albumin (Mr 66,300), and phosphorylase B (Mr 94,000). The subunit Mr of anabolic OTCase was estimated from a plot of log Mr versus electrophoretic mobility. Cross-linking of anabolic OTCase was performed as previously described (2) . The enzyme (50 jig) was dissolved in 100 ,ul of 100 mM sodium phosphate buffer (pH 7.2) containing 0.1% glutaraldehyde. After reaction at room temperature for up to 60 min, the cross-linked enzyme was boiled 5 min in 1% SDS-1% P-mercaptoethanol and then examined by electrophoresis on a 7.5% polyacrylamide gel. Amino acid analysis and N-terminal sequence. The amino acid composition and the N-terminal amino acid sequence of purified anabolic OTCase were determined as previously described (12) .
RESULTS
Subcloning of the argF(P) gene. Initially, two recombinant plasmids were available which carried the argF(P) gene of strain PA01 in the broad-host-range vector pKT240 (Fig. 1) .
The first plasmid, pME203, has a 24-kb insert of authentic P.
aeruginosa chromosomal DNA and contains the argF(P) and argG genes (29) . The second plasmid, pME202, is derived from pME203 by a spontaneous 17.4-kb deletion which eliminates argG (29) . One deletion endpoint in pME202 was localized ( Fig. 2) at a site about 0.3 kb upstream of the argF(P) transcription-initiation region (as determined by the experiment of Fig. 4 ). Mapping of the deletion endpoint was done by subcloning the argF(P) gene region from both pME202 and pME203 into pBR322 and comparing the restriction maps of the resulting recombinant plasmids pME217 and pME205 ( Fig. 1 and 2 ). Subsequent studies on argF(P) expression in P. aeruginosa (see below) showed that the segment extending from the deletion endpoint (coordinate 2.7 kb in Fig. 2 ) to the Sall site (coordinate 3.4 kb in Fig.  2 ) was not required for argF(P) enzyme synthesis and regulation by arginine, and hence both pME202 and pME203 were used for further characterization of the argF(P) gene. The argF(P) region was subcloned into pKT240 on a 2.1-kb SalI-BglII fragment from pME203 and also on a 1.6-kb XhoI-BglII fragment originating from pME202, giving pME222 and pME215, respectively ( Fig. 1 ). All recombinant plasmids (pME205, pME215, pME217, pME222) complemented the OTCase-negative E. coli mutant CM236 (argF argl).
Expression of the cloned argF(P) gene in P. aeruginosa and E. coli. In agreement with earlier results (7, 29) , the cloned argF(P) gene was expressed in E. coli at low levels and was not regulated by arginine repression ( Table 2 ). The specific activity of anabolic OTCase in E. coli CM236(pME217) was 8.4 U/mg of protein ( Table 2 ). Assuming that the pBR322 derivative pME217 has 20 to 40 copies we calculate that the argF(P) gene was expressed in E. coli at about 2% of the level in P. aeruginosa. In E. coli CM236(pME215) the OTCase level was higher (Table 2) , presumably because of readthrough from the kanamycin resistance promoter of the vector pKT240 (Fig. 1) . To test whether the cloned argF(P) gene was repressible by arginine, we transferred the broadhost-range argF(P)+ recombinant plasmids pME215 and pME222 to P. aeruginosa. Anabolic OTCase-specific activities were measured in PAO strains carrying either plasmid in glutamate medium (conditions of derepression [49] ) and in arginine medium (conditions of repression [49] ). The synthesis of the OTCase specified by pME222 was repressible by a factor of about 15, which is similar to the value found for the chromosomal argF(P) gene in the wild-type strain PAQ1 (Table 2) . PAO (29) . pME205 was constructed by cloning into pBR322 the 3.8-kb ClaI-HindIII fragment from pME202, which had been isolated from a dam' E. coli strain. The 1.6-kb XhoI-BglIll fragment of pME205 was inserted into pKT240 and pME290, generating pME215 and pME320, respectively. Cloning of the 3.4-kb HindIII-SalI fragment and the 2.1-kb Sall-BglIll fragment from pME203 into pBR322 and pKT240 gave pME217 and pME222, respectively. Abbreviations: bla, ampicillin-carbenicillin resistance gene; Kms, kanamycin susceptible; Ba, BamHI; Bg, BglII; C, ClaI; E, EcoRI; H, HindIll; K, KpnI; Pv, PvuII; S, Sall; X, XhoI. The ClaI site marked with an asterisk is methylated by dam methylase of E. coli, resulting in resistance to ClaI digestion. Heavy lines indicate P. aeruginosa DNA. vector pKT240 (20 to 40 copies in P. aeruginosa [29] ) might contribute to this growth problem, the 1.6-kb XhoI-Bgill argF(P)+ fragment was recloned into the medium-copynumber vector pME290 (ca. 7 copies [26] ), giving pME320 (Fig. 1) . Strain PA025(pME320) grew normally in arginine medium, and thus it could be demonstrated that the argF(P) gene on pME320 was repressed 13-fold by arginine (Table 2 ). This result indicates that the 1.6-kb argF(P)+ fragment contains the site(s) necessary for repression.
Size determination of the argF(P) gene and sequencing strategy. As described above, the argF(P) gene could be located on the 2.1-kb Sall-BglII fragment of pME203. Insertions into either the EcoRI site (at 1.9 kb) or the PvuII site (at 1.7 kb; Fig. 2 ) led to an ArgF-phenotype. To determine the size of the argF(P) gene and to create deletions that could be used for nucleotide sequencing, we cloned the 3.3-kb SallKpnI fragment of pME203 (Fig. 1) into pUC18, giving rise to pYIl (Fig. 2) . It was possible to construct a series of deletions from either the Sall or the BglII site by using exonuclease III (see Materials and Methods). The deletions were mapped by a combination of digestions with SacI, EcoRI, KpnI, BglII, and HindIII, and appropriate deletion plasmids were tested for the ArgF phenotype in E. coli CM236 (Fig. 2) . The argF(P) gene was found to lie between the BglII and SmaI sites (1.3 to 2.4 kb in Fig. 2 ). For nucleotide sequencing, fragments from the deletion plasmids were recloned into M13 vectors (Fig. 2) .
Nucleotide and amino acid sequences of argF(P). The 1,380-bp nucleotide sequence starting from the BglI site (at 2.6 kb in Fig. 2 ) and the deduced amino acid sequence beginning at the ATG of position 357 are shown in Fig. 3 36 ,000, which was determined for the subunit of purified enzyme by SDSpolyacrylamide gel electrophoresis (see below). The purification scheme (Table 3 ) gave an argF(P) enzyme preparation that was .98% pure according to gel electrophoresis (data not shown). The sequence of the first 37 amino acid residues from the N-terminus was determined and found to match the deduced sequence (Fig. 3) . For the amino acid residues at positions 3, 13, 21, 22, 30, and 32 there was an arginineproline ambiguity in the amino acid sequence, because the phenylthiohydantoin derivatives of arginine and proline were poorly separated in high-pressure liquid chromatography. Hence these residues were assigned according to the nucleotide sequence, which could be determined without ambiguity. The amino acid composition of the purified protein further supported the nucleotide sequence data ( BglII-HindIII or HindIII-KpnI (A S26 through A S34), and Sacl-HindIll (A B4 through A B26). The DNA regions indicated by bars (BglII-HindIII, EcoRI-HindIII, or EcoRI-SacI fragments) were cloned into M13mpl8 (_) and M13mpll (rzzI) and sequenced. The EcoRI, Sacl, PstI, and HindlIl sites at the ends of the sequences ( ) come from the vector pUC18 (52) . The ClaI site (*) is methylated in dam+ E. coli but not P. aeruginosa. The ArgF phenotype was tested by complementation in E. coli CM236: +, complemented; -, not complemented; N.T., not tested. Abbreviations: B, BglII; E, EcoRI; H, HindIII; K, KpnI; P, PstI; Sc, Sacl; Sl, SaIl. complementary to 16S rRNA of P. aeruginosa [45] ) was found 10 bp upstream of the translation-initiation codon (Fig.  3) .
Promoter sequence of argF(P). The 5' ends of argF(P) mRNA were determined by Si mapping with a 330-bp SmaI-TaqI fragment (Fig. 3) labeled at the 5' end of the TaqI site and total cellular RNA from P. aeruginosa strains and E. coli CM236(pME217). In P. aeruginosa strains PAO1 and PAO25(pME222) grown under conditions of derepression and in E. coli CM236(pME217) the same transcript (mRNA-1) could be detected which started at position 248 ± 2 (Fig.  4, lanes 1, 2, and 3) . The inferred -35 and -10 promoter sequences for mRNA-1 are underlined in Fig. 3 ; they show some homology with the E. coli -35/-10 consensus promoter sequence (38) . In the P. aeruginosa strains, a second transcript (mRNA-2) could be seen which was virtually absent from E. coli and which had an apparent start point around position 258 + 2 (Fig. 4) plasmid lacks the promoter for mRNA-1 (Fig. 3) but presumably retains the promoter for mRNA-2 (data not shown). In E. coli CM236(pME217), which carries 20 to 40 argF(P) copies, and in P. aeruginosa PAO1, which has a single chromosomal argF(P) copy, the amounts of argF(P) transcripts (mRNA-1) were comparable (Fig. 4, lanes 1 and 3) . This supports the earlier conclusion (29) that the argF(P) promoter is poorly recognized by the E. coli RNA polymerase. In strain PA025(pME222) argF(P) transcripts were abundant due to a copy number effect (Fig. 4, lane 2) . In strain PAO1 grown under conditions of repression neither mRNA-1 nor mRNA-2 was detected (Fig. 4, lane 4) . This result indicates that regulation of anabolic OTCase synthesis by arginine is transcriptional and takes place at both promoters.
Quaternary structure of purified anabolic OTCase. The Mr of purified native anabolic OTCase was estimated to be 125,000 by Sephadex G-200 gel filtration (data not shown). In an earlier experiment (32) an Mr of 110,000 had been found. In SDS-gel electrophoresis a subunit Mr of 36,000 was found. After cross-linking of the enzyme with glutaraldehyde three prominent bands of Mr 36,000, 72,000, and 108,000 were observed in SDS gels (data not shown); these bands represent the monomer, dimer, and trimer, respectively. Thus, the anabolic OTCase oi P. aeruginosa is a trimeric enzyme like the OTCases from most other organisms (9, 32, 34) . (Fig. 3) . b Determined by hydrolysis of purified enzyme, based on the calculated Mr of 33,924. (Fig. 3) . The relative amount of the sample in lane 2 was one-sixth of that in the other lanes.
DISCUSSION
Comparison of the anabolic OTCase of P. aeruginosa with the catabolic OTCase of P. aeruginosa and the anabolic
OTCases of E. coli K-12. Immunological studies had previously led to the conclusion that the catabolic OTCase of P. aeruginosa was related to the anabolic enzymes of E. coli K-12, but curiously no cross-reaction had been found between the anabolic OTCase of P. aeruginosa and antiserum directed against the E. coli argF(E) anabolic OTCase or the P. putida catabolic OTCase (12) . We can now assess this result on the basis of the complete nucleotide sequences (2, 3, 48) and the deduced amino acid sequences (Fig. 5) . The P. aeruginosa argF(P) gene has in fact significant similarity with the arcB gene of P. aeruginosa and the argF(E) and argI genes of E. coli, and these similarities are also apparent at the amino acid sequence level (Table 5) . It therefore seems likely that the antibodies used by Falmagne et al. (12) mostly recognized epitopes which are not represented on the argF(P) enzyme. Such sequences obviously exist, for example, in a region which is highly conserved in the arcB, argF(E), and argI enzymes (positions 47 through 110 in arcB; Fig. 5 ) or in segments where "gaps" had to be introduced into the argF(P) amino acid sequence to permit optimal alignment with the other sequences. The largest gap [position 266 in argF(P); Fig. 5 ] concerns a peptide which is also missing from eucaryotic OTCases (23, 46) . The second largest gap (position 194) occurs in a region of low sequence homology between procaryotic (Fig. 5) and eucaryotic (23, 46) OTCases.
Taking into account functionally similar amino acid residues (as defined in Fig. 5 ), we can state that the argF(P) enzyme has 50 to 55% similarity with the argF(E), arcB, and argI OTCases. A comparison between procaryotic and eucaryotic OTCases shows a lower degree of conservation (23, 46) . All of omithine and aspartate carbamoyltransferases studied, including the argF(P) enzyme, have two highly conserved regions, Ser-Thr-Arg-Thr-Arg and His-Pro-X-Gln [positions 53 through 57 and 131 through 134 in the argF(P) enzyme; Fig. 5 ] (2, 3, 22, 23, 33, 46, 48) . Several residues which have been shown to participate in carbamoylphosphate binding or catalysis (21, 22, 33) occur in the argF(P) enzyme within and between the conserved regions, namely, Ser-53, Arg-55, Thr-56, Arg-104, Gly-125, His-131, and Gln-134 (Fig. 5) . Furthermore, a region exists which is strongly conserved in all OTCases investigated so far (2, 23, 46) , Phe-X-His-Cys-Leu-Pro (positions 256 through 261, Fig.  5) , and which includes a Cys residue essential for ornithine binding in bovine liver and Streptococcus OTCases (36) 
At the nucleotide sequence level there is a high degree of identity between the argF(E) and argI genes of E. coli (9, 48) , whereas the argF(P) gene, which is shorter, shows less extensive similarity with these E. coli genes. The arcB gene shows more similarity with the argF(E) gene than with the argF(P) gene (Table 5 ). The G+C contents of the arcB and argF(E) genes (Table 5 ) are intermediate between the values which are typical of genomic DNA from P. aeruginosa (67% G+C) and E. coli (51% G+C) (4) . By contrast, the G+C contents of the argF(P) and argl genes are close to the typical values for the respective hosts (Table 5) . We speculate that the arcB and argF(E) genes might have evolved from a common origin, despite the fact that the products of these genes have different physiological roles.
The catabolic arcB OTCase of P. aeruginosa is an allosteric enzyme with a highly aggregated nonameric or dodecameric structure (2) . The anabolic argF(P), argF(E), and argI OTCases are all trimers displaying hyperbolic saturation kinetics (9, 32 ; this study). The catabolic enzyme of P. aeruginosa has slight anabolic activity in E. coli (2) and can undergo mutational changes that permit anabolic activity in P. aeruginosa (14 (10, 38) ; (ii) promoters with homology to the consensus sequence of ntrA (rpoN)-activated promoters in enteric bacteria (-24 region, CTGGYAY; -12 region, TTGCA) (10, 11, 30, 41) ; (iii) promoters with no apparent homology to known transcription initiation sites in enteric bacteria (13, 24, 51) . The promoter for argF(P) mRNA-1 belongs to group i, although transcription from this site (Fig.  3 ) was clearly very inefficient in E. coli (Fig. 4) . If no mRNA processing takes place, mRNA-2 is due to a second, overlapping promoter. This promoter was not used in E. coli (Fig. 4) and falls into group iii in that no consensus sequence can be recognized. Taken together, the data strengthen the concept that the expression barrier between Pseudomonas and E. coli genes is essentially at the transcriptional level (10, 24, 29) .
The Si mapping data indicate that regulation of argF(P) by arginine involves transcriptional control. The argF(P) promoter region does not contain any "arg boxes" (arginine operator modules), which typically precede the arginine biosynthetic genes in E. coli (8, 9) . It is therefore not surprising that the argF(P) gene is not controlled by the argR repressor in E. coli. The sequences involved in the regulation of argF(P) are unknown; a possible candidate sequence is YTTCC 5 or 6 bp YTTCC, which occurs three times with regular spacing in the argF(P) promoter region (Fig. 3) . Further studies are required to elucidate the mechanism of argF(P) control. Previous work (28, 49) suggests that there exists a common regulatory element for the repression of anabolic OTCase and the induction of the enzymes of the N-succinylarginine pathway, which is the major aerobic arginine catabolic pathway in P. aeruginosa (16) .
